Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Equity Average: 2024-2025

Historic Equity Average for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $392.5 million.

  • Immunocore Holdings' Equity Average rose 6.52% to $392.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.5 million, marking a year-over-year increase of 6.52%. This contributed to the annual value of $364.8 million for FY2024, which is 3.08% up from last year.
  • Immunocore Holdings' Equity Average amounted to $392.5 million in Q3 2025, which was up 2.36% from $383.5 million recorded in Q2 2025.
  • Immunocore Holdings' Equity Average's 5-year high stood at $392.5 million during Q3 2025, with a 5-year trough of $359.3 million in Q2 2024.
  • Its 2-year average for Equity Average is $372.4 million, with a median of $369.3 million in 2024.
  • Data for Immunocore Holdings' Equity Average shows a peak YoY climbed of 6.72% (in 2025) over the last 5 years.
  • Over the past 2 years, Immunocore Holdings' Equity Average (Quarterly) stood at $369.3 million in 2024, then increased by 6.52% to $392.5 million in 2025.
  • Its Equity Average stands at $392.5 million for Q3 2025, versus $383.5 million for Q2 2025 and $369.6 million for Q1 2025.